Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Siemens Demonstrates Dose Reduction in Radiology at RSNA 2010

Guide to Low Dose helps explain low dose technologies in detail


News provided by

Siemens Healthcare

Nov 28, 2010, 11:00 ET

Share this article

Share toX

Share this article

Share toX

CHICAGO, Nov. 28, 2010 /PRNewswire/ -- Siemens Healthcare has a history of reducing radiation dose in diagnostic and interventional radiology through its technical innovations. Now, Siemens is the first manufacturer to issue a "Guide to Low Dose." Created for physicians and medical technical staff, this guide describes the basics of radiation used for medical purposes, presenting a detailed explanation of dose reduction innovations on Siemens medical imaging equipment. Users can learn how these features can help provide better care to patients and assist clinical staff by minimizing the dose during examinations. Siemens is also increasing its communication activities around the low dose issues by offering numerous new seminars, training courses and presentations over the next two years. Siemens will also continue its dedication to support clinical staff and management in implementing dose monitoring and reduction measures. Siemens will demonstrate its innovations in Low Dose technology at the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), from November 28 to December 2, in booth #822, East Building/Lakeside Center, Hall D.

(Logo: http://photos.prnewswire.com/prnh/20070904/SIEMENSLOGO )

"In all relevant imaging procedures, such as computed tomography, angiography and molecular imaging, Siemens has pioneered the development of dose reduction technologies for many years," said Dr. Bernd Montag, CEO, Imaging & Therapy Systems Division, Siemens Healthcare. "Now, we're planning to launch a comprehensive education program which will support clinical staff in protecting themselves and patients better against avoidable radiation exposure. In this context, we'll be offering new training seminars, and we will provide a Guide to Low Dose, among other initiatives."

For radiological and nuclear medicine examinations that involve the use of ionizing radiation with X-ray fluoroscopy or radiodiagnostics, the medical profession generally applies the ALARA (As Low As Reasonably Achievable) principle – aimed to strike an ideal balance between the required image quality and the radiation dose. Generally, medical imaging scans require an increased dose of radiation to enhance the image quality. For its radiological devices that work with X-rays or radioactive tracers, Siemens has developed an entire range of technologies – Combined Applications to Reduce Exposure (CARE) – that enable the dose to be reduced significantly, without compromising the image quality. These technologies include, for example, IRIS (Iterative Reconstruction in Image Space), a new method for the reconstruction of CT images, High Definition PET (HD-PET), a high-resolution Positron Emission Tomography technology for molecular imaging, and a comprehensive package of dose-reduction features for interventional imaging, which are now available free of charge for our customers.

Alongside dose reduction, dose control is an important measure for avoiding unnecessary radiation. In the future, radiological devices from Siemens will issue a warning message to the user if a certain dose threshold is exceeded in critical applications. Reports are generated for examinations; these contain the patient data, the relevant protocol and the dose values. Clinics can then analyze this information, according to specific criteria, such as the dose administered, and optimize their protocols and processes accordingly.

Examples of dose reduction innovations from Siemens

Siemens was one of the pioneers of dose reduction in CT. As early as 1994, scientists and engineers from Siemens had developed CARE Dose4D™, the first fully automatic radiation exposure control technique. This was followed by ECG-synchronized dose modulation (ECG pulsing) and the Adaptive Dose Shield. ECG pulsing automatically reduces the dose during cardiograms, while the Adaptive Dose Shield is the first collimator capable of eliminating unnecessary radiation that cannot be used for image reconstruction.

In 2008, Siemens expanded its portfolio in the premium segment with the SOMATOM® Definition Flash, a dual-source CT scanner that produces an image of the entire heart in less than a quarter of a second. The radiation dose that occurs during scanning is less than one millisievert (mSv) – a value that corresponds to less than half the annual natural background radiation in Germany.

The latest innovation is FAST CARE, a hardware and software platform for CT scanners. The FAST CARE applications offer new functions and protocols for dose reduction. They also simplify time-consuming, complex procedures, such as patient scanning or preparation for image reconstruction.

Earlier this year, Siemens launched the SIERRA (Siemens Radiation Reduction Alliance) Dose Panel to advance the cause of dose reduction in computed tomography. This expert panel is comprised of 15 specialists in the fields of radiology, cardiology and physics, who are internationally recognized for their publications on the subject of dose in CT. The panel is working on generating proposals for how manufacturers can improve their technology and how users can help to bring about further dose reduction.

Since 1994, Siemens has been continuously helping to reduce dose during interventional procedures in radiology and cardiology. Siemens is not only enhancing its CARE applications with new functionality at this year's RSNA but also offering all Artis zee® customers – both existing and new – these CARE applications free of charge. This underlines Siemens' commitment to dose reduction and the optimization of treatment results in hospitals.

CARE includes new applications that reduce radiation not only for patients but also for clinical staff, as well as simplifying the post-examination documentation of the dose values. With special applications, such as radiation-free collimation and patient positioning or pulsed fluoroscopy, both the patient and the examiner are exposed to as much as 75 percent less radiation. For 3D imaging with syngo® DynaCT, there are new, particularly low-dose image acquisition protocols that enable 3D imaging for neurology from as low as 0.3 mSv, reducing the dose by up to 72 percent, compared to conventional 3D protocols.

Also new is CAREguard, which supports dose monitoring during complex interventional procedures. To help minimize applied skin dose and align with established or future regulatory requirements, physicians can use CAREguard to predefine up to three different skin dose thresholds. Once these values have been reached, physicians will receive acoustical and visual warnings so that he or she can adapt the procedure accordingly. At the end of the examination, a structured dose report documents all patient dose values, making it easier for hospitals to manage their dose reporting.

Siemens' molecular imaging technologies – SPECT (Single Photon Emission Computed Tomography), SPECT/CT and PET/CT – are designed to reduce the radiation dose for all exams, simplifying the scanning process considerably and yielding high image quality at the lowest possible dose level, even for obese and pediatric patient examinations.

Technologies, such as IRIS, TrueV and ultraHD-PET, improve the image quality and can provide for additional dose savings. The Biograph™ mCT system includes ultraHD-PET technology and ensures increased image sharpness and precision, and allows physicians to pinpoint small lesions with a smaller amount of injected radiopharmaceutical. In addition, the Symbia® S and T series systems utilize IQ-SPECT technology to reduce injected dose for cardiac studies by up to 50 percent, while also imaging patients in half the time, thereby, setting this family of systems apart from other general purpose SPECT and SPECT/CT systems on the market.

All mobile X-ray devices from Siemens ARCADIS® family are equipped with the latest dose reduction functions as standard. They include EASY (Enhanced Acquisition System), which can be used to analyze the images during acquisition to optimize dose, brightness and contrast. Even objects outside the focus are displayed with high precision. Additional copper filters, radiation-free collimation and multilevel dose control also help to ensure that the minimum necessary dose is applied. For pediatric surgery, where dose levels are most critical, the ARCADIS Avantic features a detachable grid. The devices of the ARCADIS family can also be equipped with a highly sensitive DAP (Dose Area Product) measurement chamber.

Physicians using a surgical navigation system can reduce the dose even further. NaviLink is an open interface from Siemens that enables the acquired patient dataset to be sent automatically from the mobile C-arm to the navigation system. The physician can then navigate within the patient's anatomy without the need for any further radiographs during the operation. NaviLink is optionally available for the ARCADIS Varic and for 3D imaging with the Orbic.

The mammography platform MAMMOMAT® Inspiration features a wide range of functions and technical details to minimize the radiation dose, including a special X-ray tube with a tungsten anode and new AEC algorithms that optimize the dose individually according to breast size and tissue type.

The multifunctional urology workstation UROSKOP® Omnia is also equipped with CARE programs. Pulsed fluoroscopy and radiation-free collimation and patient positioning enable the radiation dose to be reduced. In addition, the physician can adjust the dose required for acquisition and fluoroscopy to exactly the right level by selecting an organ program specially tailored to the examination being conducted.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2010 (to September 30), the Sector posted revenue of 12.4 billion euros and profit of around 750 million euros. For further information please visit: www.siemens.com/healthcare.

Not all of the products/features mentioned here are already commercially available. Some of the products/functions mentioned here already are available for purchase in some countries. Due to the legal specifications pertaining to medical devices, their future availability cannot be promised in any country. More detailed information can be obtained from the relevant local Siemens organization.

SOURCE Siemens Healthcare

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.